SFRS7 antibody
Principal name
SFRS7 antibody
Alternative names for SFRS7 antibody
Splicing factor arginine/serine-rich 7, Splicing factor 9G8
Ncbi ID
9606, NP_001026854, NP_001026854.1, NM_001031684, NM_001195446, NP_001182414.1, BC014857, NM_001195485, NM_001195486, NM_001195487
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of SFRS7 antibody
- Kit Component:
- - KN316749G1, Sfrs7 gRNA vector 1 in pCas-Guide vector
- KN316749G2, Sfrs7 gRNA vector 2 in pCas-Guide vector
- KN316749D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunofluorescence of purified MaxPab antibody to SFRS7 on HeLa cell. [antibody concentration 10 ug/ml]
Western Blot analysis of SFRS7 expression in transfected 293T cell line by SFRS7 MaxPab polyclonal antibody.Lane 1: SFRS7 transfected lysate(26.18 KDa).Lane 2: Non-transfected lysate.
Human Lung; WB Suggested Anti-SFRS7 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Lung; SFRS7 antibody - N-terminal region (ARP56231_P050) in Human Lung cells using Western Blot
Human Muscle; WB Suggested Anti-SFRS7 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Muscle; SFRS7 antibody - middle region (ARP56232_P050) in Human Muscle cells using Western Blot
Immunohistochemistry analysis in Formalin Fixed, Paraffin Embedded Human Hepatocarcinoma tissue stained with SFRS7 Antibody (N-term) Cat.-No AP53881PU-N followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of SFRS7 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Western blot analysis using SFRS7 Antibody (N-term) Cat.-No AP53881PU-N in Hela cell line lysates (35ug/lane). This demonstrates the SFRS7 antibody detected the SFRS7 protein (arrow).
Immunohistochemical analysis of SRSF7 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Western blot analysis of SRSF7 expression in HeLa (A) whole cell lysates.
Western blot analysis of extracts from HT-29 cells, using SFRS7 antibody.The lane on the right is treated with the synthesized peptide.
WB Suggested Anti-SFRS7 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:62500; Positive Control: Human Lung
WB Suggested Anti-SFRS7 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Human Muscle
Lysates
| Catalog No. | ||
|---|---|---|
| LY421899 | SRSF7 overexpression lysate |
|
 |
0.1 mg /
$295.00
|
|
| OriGene Technologies, Inc. | ||
| LY434071 | SRSF7 overexpression lysate |
|
|
0.1 mg /
$315.00
|
|
| OriGene Technologies, Inc. |